Ropes & Gray represented Xeris Biopharma on the deal.Xeris Biopharma announced a research collaboration and option agreement with Horizon Therapeutics. Under the agreement announced on November 23,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
